Eli Lilly Escapes Cymbalta User's Withdrawal Class Action

By Dani Kass (July 6, 2016, 7:51 PM EDT) -- An Indiana federal judge on Wednesday dismissed a proposed class action alleging Eli Lilly & Co. concealed the withdrawal risks of its antidepressant Cymbalta, saying the consumer who brought the suit failed to tell the court if she intended to continue the case after her attorney withdrew....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!